Automatic Intent-Slot Induction for Dialogue Systems

Automatically and accurately identifying user intents and filling the associated slots from their spoken language are critical to the success of dialogue systems. Traditional methods require manually defining the DOMAIN-INTENT-SLOT schema and asking many domain experts to annotate the corresponding utterances, upon which neural models are trained. This procedure brings the challenges of information sharing hindering, out-of-schema, or data sparsity in open-domain dialogue systems. To tackle these challenges, we explore a new task of {\em automatic intent-slot induction} and propose a novel domain-independent tool. That is, we design a coarse-to-fine three-step procedure including Role-labeling, Concept-mining, And Pattern-mining (RCAP): (1) role-labeling: extracting keyphrases from users' utterances and classifying them into a quadruple of coarsely-defined intent-roles via sequence labeling; (2) concept-mining: clustering the extracted intent-role mentions and naming them into abstract fine-grained concepts; (3) pattern-mining: applying the Apriori algorithm to mine intent-role patterns and automatically inferring the intent-slot using these coarse-grained intent-role labels and fine-grained concepts. Empirical evaluations on both real-world in-domain and out-of-domain datasets show that: (1) our RCAP can generate satisfactory SLU schema and outperforms the state-of-the-art supervised learning method; (2) our RCAP can be directly applied to out-of-domain datasets and gain at least 76\% improvement of F1-score on intent detection and 41\% improvement of F1-score on slot filling; (3) our RCAP exhibits its power in generic intent-slot extractions with less manual effort, which opens pathways for schema induction on new domains and unseen intent-slot discovery for generalizable dialogue systems.

An End-to-End Dialogue State Tracking System with Machine Reading Comprehension and Wide & Deep Classification

This paper describes our approach in DSTC 8 Track 4: Schema-Guided Dialogue State Tracking. The goal of this task is to predict the intents and slots in each user turn to complete the dialogue state tracking (DST) based on the information provided by the task's schema. Different from traditional stage-wise DST, we propose an end-to-end DST system to avoid error accumulation between the dialogue turns. The DST system consists of a machine reading comprehension (MRC) model for non-categorical slots and a Wide & Deep model for categorical slots. As far as we know, this is the first time that MRC and Wide & Deep model are applied to DST problem in a fully end-to-end way. Experimental results show that our framework achieves an excellent performance on the test dataset including 50% zero-shot services with a joint goal accuracy of 0.8652 and a slot tagging F1-Score of 0.9835.

Multi Scale Supervised 3D U-Net for Kidney and Tumor Segmentation

U-Net has achieved huge success in various medical image segmentation challenges. Kinds of new architectures with bells and whistles might succeed in certain dataset when employed with optimal hyper-parameter, but their generalization always can't be guaranteed. Here, we focused on the basic U-Net architecture and proposed a multi scale supervised 3D U-Net for the segmentation task in KiTS19 challenge. To enhance the performance, our work can be summarized as three folds: first, we used multi scale supervision in the decoder pathway, which could encourage the network to predict right results from the deep layers; second, with the aim to alleviate the bad effect from the sample imbalance of kidney and tumor, we adopted exponential logarithmic loss; third, a connected-component based post processing method was designed to remove the obviously wrong voxels. In the published KiTS19 training dataset (totally 210 patients), we divided 42 patients to be test dataset and finally obtained DICE scores of 0.969 and 0.805 for the kidney and tumor respectively. In the challenge, we finally achieved the 7th place among 106 teams with the Composite Dice of 0.8961, namely 0.9741 for kidney and 0.8181 for tumor.